187 related articles for article (PubMed ID: 25382971)
41. Expression and promoter methylation changes of the P15INK4b during ex vivo cord blood CD34+ cell expansion following co-culture with mesenchymal stromal cells.
Amirizadeh N; Oodi A; Nikougoftar M; Soltanpour MS
Hematology; 2013 Sep; 18(5):260-8. PubMed ID: 24020488
[TBL] [Abstract][Full Text] [Related]
42. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
43. Strategies to re-express epigenetically silenced p15(INK4b) and p21(WAF1) genes in acute myeloid leukemia.
Geyer CR
Epigenetics; 2010; 5(8):696-703. PubMed ID: 21124069
[TBL] [Abstract][Full Text] [Related]
44. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
[TBL] [Abstract][Full Text] [Related]
45. Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma.
Chim CS; Wong KY; Loong F; Lam WW; Srivastava G
Hum Pathol; 2007 Dec; 38(12):1849-57. PubMed ID: 17900658
[TBL] [Abstract][Full Text] [Related]
46. Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation.
Wong IH; Ng MH; Lee JC; Lo KW; Chung YF; Huang DP
Br J Haematol; 1998 Oct; 103(1):168-75. PubMed ID: 9792305
[TBL] [Abstract][Full Text] [Related]
47. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K
Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845
[TBL] [Abstract][Full Text] [Related]
48. Several mechanisms lead to the inactivation of the CDKN2A (P16), P14ARF, or CDKN2B (P15) genes in the GCB and ABC molecular DLBCL subtypes.
Guney S; Jardin F; Bertrand P; Mareschal S; Parmentier F; Picquenot JM; Tilly H; Bastard C
Genes Chromosomes Cancer; 2012 Sep; 51(9):858-67. PubMed ID: 22619049
[TBL] [Abstract][Full Text] [Related]
49. Hypermethylation of the p15INK4B gene promoter in B-chronic lymphocytic leukemia.
Papageorgiou SG; Lambropoulos S; Pappa V; Economopoulou C; Kontsioti F; Papageorgiou E; Tsirigotis P; Dervenoulas J; Economopoulos T
Am J Hematol; 2007 Sep; 82(9):824-5. PubMed ID: 17546638
[TBL] [Abstract][Full Text] [Related]
50. p15(INK4b) plays a crucial role in murine lymphoid development and tumorigenesis.
Osei-Sarfo K; de Castro IP; Pellicer A
Carcinogenesis; 2012 Mar; 33(3):708-13. PubMed ID: 22227036
[TBL] [Abstract][Full Text] [Related]
51. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of CDKN2C/p18, CDKN1B/p27 and CDKN2B/p15 mRNA expression, and CpG methylation status in sporadic and MEN1-associated pancreatic endocrine tumours.
Lindberg D; Akerström G; Westin G
Clin Endocrinol (Oxf); 2008 Feb; 68(2):271-7. PubMed ID: 17803708
[TBL] [Abstract][Full Text] [Related]
53. Oct-1 is involved in the transcriptional repression of the p15(INK4b) gene.
Hitomi T; Matsuzaki Y; Yasuda S; Kawanaka M; Yogosawa S; Koyama M; Tantin D; Sakai T
FEBS Lett; 2007 Mar; 581(6):1087-92. PubMed ID: 17316622
[TBL] [Abstract][Full Text] [Related]
54. [Detection of High Methylation of p15(INK4B) and p16(INK4A) Genes in Multiple Myeloma].
Fan H; Guo X; Wu Q; Zhou T; Tan G; Wang L; Zhang X; Luo G; Xu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2000 Dec; 8(4):271-274. PubMed ID: 12578664
[TBL] [Abstract][Full Text] [Related]
55. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
[TBL] [Abstract][Full Text] [Related]
56. Hypermethylation of the Ink4b locus in murine myeloid leukemia and increased susceptibility to leukemia in p15(Ink4b)-deficient mice.
Wolff L; Garin MT; Koller R; Bies J; Liao W; Malumbres M; Tessarollo L; Powell D; Perella C
Oncogene; 2003 Dec; 22(58):9265-74. PubMed ID: 14681685
[TBL] [Abstract][Full Text] [Related]
57. Downregulation of HO-1 promoted apoptosis induced by decitabine via increasing p15INK4B promoter demethylation in myelodysplastic syndrome.
Ma D; Fang Q; Wang P; Gao R; Sun J; Li Y; Hu XY; Wang JS
Gene Ther; 2015 Apr; 22(4):287-96. PubMed ID: 25652099
[TBL] [Abstract][Full Text] [Related]
58. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
59. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
60. Clinical and prognostic effects of
Xia L; Zhang W; Gao L
Biomarkers; 2019 Nov; 24(7):700-711. PubMed ID: 31382782
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]